Top Law News Patents law provisions conflicting, Novartis tells SC September 19, 2012 by Legal India Admin | Leave a Comment Swiss pharma company Novartis Tuesday told the Supreme Court that there cannot be conflicting provisions in a patents statute where one provision recognises innovation in drug development and another knocks it down. Novartis told an apex court bench of Justice Aftab Alam and Justice Ranjana Prakash Desai that once the Intellectual Property Appellate Board (IPAB) […] Read more ยป Additional Solicitor General Paras Kuhad chronic myeloid leukemia imatinib mesylate Intellectual Property Appellate Board IPAB verdict declining patent to Novartis anti-cancer drug Glivec Justice Aftab Alam Justice Ranjana Prakash Desai malignant gastrointestinal stromal tumors Novartis tells SC Patents law Patents law provisions conflicting pharmaceutical efficacy pharmaceutical giant challenging the IPAB pharmaceutical product Glivec Patents Act senior counsel Gopal Subramanium Subramanium Swiss pharma company Novartis